AstraZeneca Diabetes Drug Shows Promise in Severe Kidney Condition AstraZeneca Diabetes Drug Shows Promise in Severe Kidney Condition

Dapagliflozin has shown promise in a late-stage trial to help to slow chronic kidney disease, putting it on track for possible expanded approvals ahead of rival drugs.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news